Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice

Tohru Hasegawa, Nobuyuki Mikoda, Masashi Kitazawa et al. · 2010

Read Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice by Tohru Hasegawa, Nobuyuki Mikoda, Masashi Kitazawa et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008593.txt.

Description

Tohru Hasegawa and co-authors test an antibody in Alzheimer mice in a 2010 PLOS ONE paper. Alzheimer disease is a brain disorder of old age that causes dementia. Its exact causes remain unknown. The team had reported a compound called homocysteic acid as a marker in Alzheimer brains. That compound may help drive nerve cell damage. They treat male mice bred to model the disease with an antibody against it.

The antibody helps the immune system clear the compound. The team then check symptoms and brain changes in treated mice. If the marker is truly harmful, clearing it should help. The study tests a therapy aimed at a marker, not at amyloid.

Catalog record

CREATORTohru Hasegawa, Nobuyuki Mikoda, Masashi Kitazawa et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008593

Browse the full library · About the Tower of Babel